Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s): RQHTF

Healthcare Medical Devices

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.

TSXV:RHT.H - Post by User

Reliq Health Technologies Inc

Bullboard Posts

Comment by PoorOpinionon May 30, 2018 10:20am

106 Views

Post# 28098668

RE:RE:RE:Surprised.

I was really talking about CareOne's ability to execute on on-boarding, that is an unknown quantity to us. I agree when the real world hits you in the face with problems you need to react and Reliq are clearly doing that , you have to give them credit. But the business model is changing there's no denying that, all I want to do is understand that change. In my mind your answer says we're just on a new path to the Promised Land, I prefer to worry a bit more.

I think we will get more clarity tomorrow. Lisa is obviously not worried about talking about problems, the fact this PR was open about the fact they are struggling to on-board and sign new contracts is more than most CEO's would admit.

digitel wrote:
"Cost??? Execution??? Margins???"

Two new revenue streams,
and execution that shows RHT's management can deal with problems as they arise and emerge stronger than ever. RHT can now support stronger onboarding in the future!

Given the 27,500 blood pressure and blood glucose monitoring devices ordered this week we now have clear line of vision to 39,500 patients! The biggest risk is does the technology work and given the large order which is a vote of confidence concerning the full execution of the contracts, and expansion by 5,000 patients last month by one client, RHT's software has been validated with its two largest clients over the last nine months since the 'go-live' decision and through the onboarding of 12,000 patients. Having now worked out the kinks concerning two clients with 48,000 patients and validated the software future onboarding can be performed more smoothly. New prospective clients can move forward with confidence.